Navigating the Redox Precipice: Metabolic Gatekeeping as a Therapeutic Window in Pancreatic Precancer

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal malignancy largely because its early stages evade detection. Two recent studies by Hennequart et al. and Radyk et al. (2026, Nature Metabolism) agree on the following concept: pancreatic acinar cells must maintain a narrow "redox precipice" during acinar-to-ductal metaplasia (ADM), the initial reversible precursor of PDAC. Redundant nicotinamide adenine dinucleotide phosphate-generating systems-mitochondrial aldehyde dehydrogenase 1 family member L2 and cytosolic glucose-6-phosphate dehydrogenase/malic enzyme 1-generally regulate reactive oxygen species within a range that facilitates pro-survival signaling without inducing cell death. Disruption of these systems promotes ADM formation and pancreatic intraepithelial neoplasia, whereas antioxidant treatment inhibits progression. This Opinion integrates these findings within a broader framework of metabolic gatekeeping, discusses how the redox precipice interacts with epigenetic reprogramming and immune evasion, and proposes that the transition from redox balance to addiction results in stage-specific vulnerabilities. Circulating formate emerges as a promising biomarker for early detection, and we highlight key unanswered questions, including whether similar principles apply to other metaplasia-driven malignancies.